These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
783 related articles for article (PubMed ID: 30173577)
1. Stimuli-responsive nanoscale drug delivery systems for cancer therapy. Li L; Yang WW; Xu DG J Drug Target; 2019 Apr; 27(4):423-433. PubMed ID: 30173577 [TBL] [Abstract][Full Text] [Related]
2. Advances in intelligent-responsive nanocarriers for cancer therapy. Tian M; Xin X; Wu R; Guan W; Zhou W Pharmacol Res; 2022 Apr; 178():106184. PubMed ID: 35301111 [TBL] [Abstract][Full Text] [Related]
3. Classification of stimuli-responsive polymers as anticancer drug delivery systems. Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737 [TBL] [Abstract][Full Text] [Related]
4. Recent Advances in Stimuli-Responsive Release Function Drug Delivery Systems for Tumor Treatment. Ding C; Tong L; Feng J; Fu J Molecules; 2016 Dec; 21(12):. PubMed ID: 27999414 [TBL] [Abstract][Full Text] [Related]
5. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery. Baeza A; Colilla M; Vallet-RegĂ M Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898 [TBL] [Abstract][Full Text] [Related]
6. Stimuli-responsive drug delivery systems for head and neck cancer therapy. Liang J; Yang B; Zhou X; Han Q; Zou J; Cheng L Drug Deliv; 2021 Dec; 28(1):272-284. PubMed ID: 33501883 [TBL] [Abstract][Full Text] [Related]
7. The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy. Wu F; Qiu F; Wai-Keong SA; Diao Y Anticancer Agents Med Chem; 2021; 21(10):1202-1215. PubMed ID: 32972353 [TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review. Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479 [TBL] [Abstract][Full Text] [Related]
9. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy. Saravanakumar K; Hu X; Ali DM; Wang MH Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055 [TBL] [Abstract][Full Text] [Related]
10. Enzyme responsive drug delivery systems in cancer treatment. Shahriari M; Zahiri M; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M J Control Release; 2019 Aug; 308():172-189. PubMed ID: 31295542 [TBL] [Abstract][Full Text] [Related]
11. Stimuli-responsive chitosan-based nanocarriers for cancer therapy. Fathi M; Sahandi Zangabad P; Majidi S; Barar J; Erfan-Niya H; Omidi Y Bioimpacts; 2017; 7(4):269-277. PubMed ID: 29435435 [No Abstract] [Full Text] [Related]
12. Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases. Sufi SA; Pajaniradje S; Mukherjee V; Rajagopalan R Antioxid Redox Signal; 2019 Feb; 30(5):762-785. PubMed ID: 29334759 [TBL] [Abstract][Full Text] [Related]
13. Stimuli-responsive Carriers for Controlled Intracellular Drug Release. Sheng Y; Hu J; Shi J; Lee LJ Curr Med Chem; 2019; 26(13):2377-2388. PubMed ID: 28875840 [TBL] [Abstract][Full Text] [Related]
14. Redox-responsive smart nanogels for intracellular targeting of therapeutic agents: applications and recent advances. Ghorbani M; Hamishehkar H J Drug Target; 2019 Apr; 27(4):408-422. PubMed ID: 30124074 [TBL] [Abstract][Full Text] [Related]
15. Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release. Raza A; Rasheed T; Nabeel F; Hayat U; Bilal M; Iqbal HMN Molecules; 2019 Mar; 24(6):. PubMed ID: 30901827 [TBL] [Abstract][Full Text] [Related]
16. Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications. Chakraborty S; Dhakshinamurthy GS; Misra SK J Biomed Mater Res A; 2017 Oct; 105(10):2906-2928. PubMed ID: 28643475 [TBL] [Abstract][Full Text] [Related]
17. Smart Drug Delivery Systems in Cancer Therapy. Unsoy G; Gunduz U Curr Drug Targets; 2018 Feb; 19(3):202-212. PubMed ID: 27033191 [TBL] [Abstract][Full Text] [Related]
18. Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release. Tang Q; Yu B; Gao L; Cong H; Song N; Lu C Curr Med Chem; 2018; 25(16):1837-1866. PubMed ID: 29332566 [TBL] [Abstract][Full Text] [Related]
19. The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems. Foglietta F; Serpe L; Canaparo R Cells; 2021 Nov; 10(12):. PubMed ID: 34943803 [TBL] [Abstract][Full Text] [Related]
20. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades. Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]